ARTICLE | Clinical News
Ixiaro regulatory update
November 22, 2010 8:00 AM UTC
Intercell disclosed in its 3Q10 earnings that Hong Kong approved Ixiaro to prevent Japanese encephalitis (JE) infection. The company said it expects partner Novartis AG (NYSE:NVS; SIX:NOVN, Basel, Sw...